Literature DB >> 28395011

Metabolism in cardiomyopathy: every substrate matters.

Julia Ritterhoff, Rong Tian.   

Abstract

Cardiac metabolism is highly adaptive to changes in fuel availability and the energy demand of the heart. This metabolic flexibility is key for the heart to maintain its output during the development and in response to stress. Alterations in substrate preference have been observed in multiple disease states; a clear understanding of their impact on cardiac function in the long term is critical for the development of metabolic therapies. In addition, the contribution of cellular metabolism to growth, survival, and other signalling pathways through the generation of metabolic intermediates has been increasingly noted, adding another layer of complexity to the impact of metabolism on cardiac function. In a quest to understand the complexity of the cardiac metabolic network, genetic tools have been engaged to manipulate cardiac metabolism in a variety of mouse models. The ability to engineer cardiac metabolism in vivo has provided tremendous insights and brought about conceptual innovations. In this review, we will provide an overview of the cardiac metabolic network and highlight alterations observed during cardiac development and pathological hypertrophy. We will focus on consequences of altered substrate preference on cardiac response to chronic stresses through energy providing and non-energy providing pathways. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cardiac metabolism; Energy metabolism; Metabolic flexibility; Metabolic signalling; Pathological hypertrophy

Mesh:

Year:  2017        PMID: 28395011      PMCID: PMC5852620          DOI: 10.1093/cvr/cvx017

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  121 in total

1.  Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress.

Authors:  Ivan Luptak; Jie Yan; Lei Cui; Mohit Jain; Ronglih Liao; Rong Tian
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

Review 2.  Cardiac metabolism in heart failure: implications beyond ATP production.

Authors:  Torsten Doenst; Tien Dung Nguyen; E Dale Abel
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

3.  Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.

Authors:  Ryan Lahey; Xuerong Wang; Andrew N Carley; E Douglas Lewandowski
Journal:  Circulation       Date:  2014-09-29       Impact factor: 29.690

4.  Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.

Authors:  Susan A Marsh; Louis J Dell'Italia; John C Chatham
Journal:  Amino Acids       Date:  2010-07-30       Impact factor: 3.520

5.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

Authors:  Laura L Listenberger; Xianlin Han; Sarah E Lewis; Sylvaine Cases; Robert V Farese; Daniel S Ory; Jean E Schaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

6.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

7.  Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy.

Authors:  Danilo Neglia; Alberto De Caterina; Paolo Marraccini; Andrea Natali; Marco Ciardetti; Cecilia Vecoli; Amalia Gastaldelli; Demetrio Ciociaro; Paola Pellegrini; Roberto Testa; Luca Menichetti; Antonio L'Abbate; William C Stanley; Fabio A Recchia
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-10-05       Impact factor: 4.733

Review 8.  Ketone bodies as signaling metabolites.

Authors:  John C Newman; Eric Verdin
Journal:  Trends Endocrinol Metab       Date:  2013-10-18       Impact factor: 12.015

9.  Ketones Step to the Plate: A Game Changer for Metabolic Remodeling in Heart Failure?

Authors:  Stephen C Kolwicz; Sophia Airhart; Rong Tian
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

10.  Cardiomyocyte-Restricted Deletion of PPARβ/δ in PPARα-Null Mice Causes Impaired Mitochondrial Biogenesis and Defense, but No Further Depression of Myocardial Fatty Acid Oxidation.

Authors:  Jian Liu; Peiyong Wang; Lan He; Yuquan Li; Jinwen Luo; Lihong Cheng; Qianhong Qin; Lawrence A Brako; Woo-Kuen Lo; William Lewis; Qinglin Yang
Journal:  PPAR Res       Date:  2011-09-05       Impact factor: 4.964

View more
  68 in total

1.  Metabolic cardiomyopathies - fighting the next epidemic.

Authors:  Christoph Maack; Elizabeth Murphy
Journal:  Cardiovasc Res       Date:  2017-02-16       Impact factor: 10.787

2.  GRP78 (Glucose-Regulated Protein of 78 kDa) Promotes Cardiomyocyte Growth Through Activation of GATA4 (GATA-Binding Protein 4).

Authors:  Guangyu Zhang; Xiaoding Wang; Xukun Bi; Chao Li; Yingfeng Deng; Ali A Al-Hashimi; Xiang Luo; Thomas G Gillette; Richard C Austin; Yanggan Wang; Zhao V Wang
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 3.  Emerging therapies for right ventricular dysfunction and failure.

Authors:  Anna Klinke; Torben Schubert; Marion Müller; Ekaterina Legchenko; Jason G E Zelt; Tsukasa Shimauchi; L Christian Napp; Alexander M K Rothman; Sébastien Bonnet; Duncan J Stewart; Georg Hansmann; Volker Rudolph
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

4.  Caffeic Acid Protects against Iron-Induced Cardiotoxicity by Suppressing Angiotensin-Converting Enzyme Activity and Modulating Lipid Spectrum, Gluconeogenesis and Nucleotide Hydrolyzing Enzyme Activities.

Authors:  Veronica F Salau; Ochuko L Erukainure; Md Shahidul Islam
Journal:  Biol Trace Elem Res       Date:  2020-06-06       Impact factor: 3.738

Review 5.  Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure.

Authors:  Alexander Dietl; Christoph Maack
Journal:  Curr Heart Fail Rep       Date:  2017-08

6.  Endothelial EphB4 maintains vascular integrity and transport function in adult heart.

Authors:  Guillermo Luxán; Jonas Stewen; Mara E Pitulescu; Ralf H Adams; Noelia Díaz; Katsuhiro Kato; Sathish K Maney; Anusha Aravamudhan; Frank Berkenfeld; Nina Nagelmann; Hannes Ca Drexler; Dagmar Zeuschner; Cornelius Faber; Hermann Schillers; Sven Hermann; John Wiseman; Juan M Vaquerizas
Journal:  Elife       Date:  2019-11-29       Impact factor: 8.140

Review 7.  Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.

Authors:  Chrishan J A Ramachandra; Jasper Chua; Shuo Cong; Myu Mai Ja Kp; Winston Shim; Joseph C Wu; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

Review 8.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

Review 9.  Considerations for using isolated cell systems to understand cardiac metabolism and biology.

Authors:  Lindsey A McNally; Tariq R Altamimi; Kyle Fulghum; Bradford G Hill
Journal:  J Mol Cell Cardiol       Date:  2020-12-21       Impact factor: 5.000

Review 10.  Use of cardiac magnetic resonance to detect changes in metabolism in heart failure.

Authors:  William D Watson; Jack J J Miller; Andrew Lewis; Stefan Neubauer; Damian Tyler; Oliver J Rider; Ladislav Valkovič
Journal:  Cardiovasc Diagn Ther       Date:  2020-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.